236 related articles for article (PubMed ID: 23045147)
1. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
Li AP
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
3. Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry.
Lahoz A; Donato MT; Castell JV; Gómez-Lechón MJ
Curr Drug Metab; 2008 Jan; 9(1):12-9. PubMed ID: 18220567
[TBL] [Abstract][Full Text] [Related]
4. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
5. Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry.
Szultka-Mlynska M; Buszewski B
Anal Bioanal Chem; 2016 Nov; 408(29):8273-8287. PubMed ID: 27704178
[TBL] [Abstract][Full Text] [Related]
6. A new in vitro approach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations.
Lahoz A; Donato MT; Montero S; Castell JV; Gómez-Lechón MJ
Rapid Commun Mass Spectrom; 2008; 22(2):240-4. PubMed ID: 18088071
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Drug Metabolism Using Liver Microsomes.
Knights KM; Stresser DM; Miners JO; Crespi CL
Curr Protoc Pharmacol; 2016 Sep; 74():7.8.1-7.8.24. PubMed ID: 27636111
[TBL] [Abstract][Full Text] [Related]
8. [Liver and drug metabolism].
Mikheeva OM
Eksp Klin Gastroenterol; 2011; (2):121-4. PubMed ID: 21560652
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry.
Lahoz A; Donato MT; Picazo L; Castell JV; Gómez-Lechón MJ
Drug Metab Lett; 2008 Aug; 2(3):205-9. PubMed ID: 19356095
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites.
Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS
Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376
[TBL] [Abstract][Full Text] [Related]
11. Assessment of competitive and mechanism-based inhibition by clarithromycin: use of domperidone as a CYP3A probe-drug substrate and various enzymatic sources including a new cell-based assay with freshly isolated human hepatocytes.
Michaud V; Turgeon J
Drug Metab Lett; 2010 Apr; 4(2):69-76. PubMed ID: 20446912
[TBL] [Abstract][Full Text] [Related]
12. In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP.
Yamane M; Kawashima K; Yamaguchi K; Nagao S; Sato M; Suzuki M; Honda K; Hagita H; Kuhlmann O; Poirier A; Fowler S; Funk C; Simon S; Aso Y; Ikeda S; Ishigai M
Xenobiotica; 2015 Mar; 45(3):230-8. PubMed ID: 25350082
[TBL] [Abstract][Full Text] [Related]
13. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
14. Role of human liver microsomes in in vitro metabolism of drugs-a review.
Asha S; Vidyavathi M
Appl Biochem Biotechnol; 2010 Mar; 160(6):1699-722. PubMed ID: 19582595
[TBL] [Abstract][Full Text] [Related]
15. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
16. An update on metabolism studies using human hepatocytes in primary culture.
Gómez-Lechón MJ; Castell JV; Donato MT
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):837-54. PubMed ID: 18624674
[TBL] [Abstract][Full Text] [Related]
17. Human hepatocytes: isolation, cryopreservation and applications in drug development.
Li AP
Chem Biol Interact; 2007 May; 168(1):16-29. PubMed ID: 17270162
[TBL] [Abstract][Full Text] [Related]
18. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of hepatocytes in drug discovery.
Soars MG; McGinnity DF; Grime K; Riley RJ
Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
[TBL] [Abstract][Full Text] [Related]
20. The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction.
Klieber S; Torreilles F; Guillou F; Fabre G
Methods Mol Biol; 2010; 640():295-308. PubMed ID: 20645059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]